Cargando...
Impact of High Deductible Insurance on Adjuvant Hormonal Therapy Use in Breast Cancer
OBJECTIVE: High-deductible health plans (HDHP) have become the predominant commercial health insurance arrangement in the United States. HDHPs require substantial out-of-pocket (OOP) costs for most services but often exempt medications from high cost sharing. We examined effects of HDHPs on OOP cost...
Guardado en:
| Publicado en: | Breast Cancer Res Treat |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6231999/ https://ncbi.nlm.nih.gov/pubmed/29754304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-018-4821-z |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|